Are you Dr. Sierra-Hoffman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2710 Hospital Dr
#310
Victoria, TX 77901Phone+1 361-582-7925Fax+1 361-582-7926
Summary
- Dr. Miguel Sierra-Hoffman, MD is an infectious disease specialist in Victoria, Texas. He is currently licensed to practice medicine in Texas, Washington, and Alabama. He is affiliated with Citizens Medical Center, PAM Specialty Hospital of Victoria South, and DeTar Healthcare System.
Education & Training
- USA HealthFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2006
- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Fellowship, Infectious Disease, 2002 - 2004
- Mercy Catholic Medical CenterResidency, Internal Medicine, 1999 - 2002
- Universidad Nacional Autonoma de Honduras Class of 1991
Certifications & Licensure
- WA State Medical License 2011 - 2026
- TX State Medical License 2005 - 2025
- AL State Medical License 2004 - 2006
- PA State Medical License 1999 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies.Fernando Valerio-Pascua, Fernando Baires, Anupamjeet Kaur Sekhon, Mari L Tesch, Estela Jackeline Pineda
BMC Infectious Diseases. 2024-11-26 - Typhus group Rickettsia community-acquired bacterial central nervous system infections: We must think outside the box!Pauline B Roxas, Justice Cruz, Nicole Rae Horelka, Cesar Burgos, Jana Radwanski
Journal of the Neurological Sciences. 2024-11-15 - 7 citationsImpact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study.Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires
Frontiers in Pharmacology. 2022-01-01
Press Mentions
- Did Dismissals of Safe Outpatient Drugs Cause Needless Covid Deaths? Dissenting Doctors Say YesDecember 21st, 2021